MDA-9/Syntenin (SDCBP) modulates small GTPases RhoA and Cdc42 via transforming growth factor β1 to enhance epithelial-mesenchymal transition in breast cancer.
about
Oridonin inhibits migration, invasion, adhesion and TGF-β1-induced epithelial-mesenchymal transition of melanoma cells by inhibiting the activity of PI3K/Akt/GSK-3β signaling pathway.The MDA-9/Syntenin/IGF-1R/STAT3 axis directs prostate cancer invasion.MDA-9/Syntenin regulates protective autophagy in anoikis-resistant glioma stem cells.
P2860
MDA-9/Syntenin (SDCBP) modulates small GTPases RhoA and Cdc42 via transforming growth factor β1 to enhance epithelial-mesenchymal transition in breast cancer.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
MDA-9/Syntenin (SDCBP) modulat ...... l transition in breast cancer.
@en
MDA-9/Syntenin
@nl
type
label
MDA-9/Syntenin (SDCBP) modulat ...... l transition in breast cancer.
@en
MDA-9/Syntenin
@nl
prefLabel
MDA-9/Syntenin (SDCBP) modulat ...... l transition in breast cancer.
@en
MDA-9/Syntenin
@nl
P2093
P2860
P356
P1433
P1476
MDA-9/Syntenin (SDCBP) modulat ...... l transition in breast cancer.
@en
P2093
Devanand Sarkar
Luni Emdad
Mitchell E Menezes
Paul B Fisher
Swadesh K Das
Xue-Ning Shen
P2860
P304
80175-80189
P356
10.18632/ONCOTARGET.13373
P407
P577
2016-11-15T00:00:00Z